Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial

Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:32:55.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2; no visible changes to study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:44:32.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. No clinical trial details or study information were changed.
    Difference
    0.4%
    Check dated 2025-11-18T06:54:22.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    No significant differences in the core Study Details page (NCT03143036) between the two screenshots; the study information appears unchanged aside from minor formatting. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:03.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Major update to page content with new government status notice and NIH Clinical Center operating status, plus version bump to v3.2.0; removal of a specific genetic disease resource (Multiple myeloma) and downgrade from v3.1.0 to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:36:39.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Core term updated from Plasma cell myeloma to Multiple myeloma; new version v3.1.0; added identifier/phone-like number 6779 5555.
    Difference
    0.2%
    Check dated 2025-09-29T03:07:36.000Z thumbnail image

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.